Simvastatin, Atorvastatin, and Pravastatin Equally Improve the Hemodynamic Status of Diabetic Rats

Overview

Journal World J Diabetes

Publisher Baishideng Publishing Group

Specialty Endocrinology

Date 2015 Sep 1

PMID 26322162

Citations 8

Authors

Maria J Crespo

Jose Quidgley

Affiliations

Soon will be listed here.

Abstract

Aim: To investigate if the effect of statins improving cardiovascular (CV) status of diabetics is drug-specific or class-dependent, and the underlying mechanisms involved.

Methods: We compared the results of daily administration over a four-week period of a low dose (10 mg/kg per day) of atorvastatin (AV), simvastatin (SV), and pravastatin (PV) on cardiac performance in diabetic rats. Echocardiographic variables were tested, as well as systolic blood pressure (SBP), acetylcholine (ACh)-induced relaxation, plasma cholesterol levels, and perivascular fibrosis. Malondialdehyde (MDA) and 4-hydroxyalkenal (4-HAE), and endothelial nitric oxide synthase (eNOS) and inducible nitric oxide synthase (iNOS) protein levels were also measured in cardiac and aortic homogenates.

Results: In untreated diabetic rats, cholesterol levels were higher than in control rats (CT; n = 8, P < 0.05), and the low dose of statins used did not modify these levels. In diabetic rats, SBP was higher than in CT, and was significantly reduced by all three statins (n = 10, P < 0.05). Echocardiographic parameters (EF, SV, and COI) were all lower in untreated diabetic rats than in CT (n = 10, P < 0.05). These CV parameters were equally improved by all three statins. The maximal relaxation (EMax) induced by ACh in aortic ring from diabetic rats was also improved. Moreover, this relaxation was abolished by 1 mmol/L NG-nitro-L-arginine methyl ester, suggesting the involvement of a NO-dependent mechanism.

Conclusion: AV, SV, and PV are equally effective in improving CV performance in diabetic rats. All tree statins decreased media thickness, perivascular fibrosis, and both MDA and 4-HAE in the aortas of diabetic rats, without affecting eNOS and iNOS protein levels. The observed hemodynamic benefits are cholesterol-independent. These benefits appear to be secondary to the improved endothelial function, and to the reduced vascular tone and remodeling that result from decreased oxidative stress.

Citing Articles

Evaluation of the toxicity potential of exercise and atorvastatin/metformin combination therapy on STZ-diabetic rats.

Tuncyurekli M, Tuluce Y, Erciyas F Naunyn Schmiedebergs Arch Pharmacol. 2024; .

PMID: 39625487 DOI: 10.1007/s00210-024-03663-x.

Evodiamine decreased the systemic exposure of pravastatin in non-alcoholic steatohepatitis rats due to the up-regulation of hepatic OATPs.

Liang R, Ge W, Li B, Cui W, Ma X, Pan Y Pharm Biol. 2022; 60(1):359-373.

PMID: 35171063 PMC: 8856114. DOI: 10.1080/13880209.2022.2036767.

Direct Activation of Endothelial Cells by SARS-CoV-2 Nucleocapsid Protein Is Blocked by Simvastatin.

Qian Y, Lei T, Patel P, Lee C, Monaghan-Nichols P, Xin H J Virol. 2021; 95(23):e0139621.

PMID: 34549987 PMC: 8577385. DOI: 10.1128/JVI.01396-21.

The combination of dantrolene and nimodipine effectively reduces 5-HT-induced vasospasms in diabetic rats.

Roman M, Garcia L, Morales M, Crespo M Sci Rep. 2021; 11(1):9852.

PMID: 33972638 PMC: 8110522. DOI: 10.1038/s41598-021-89338-6.

Direct activation of endothelial cells by SARS-CoV-2 nucleocapsid protein is blocked by Simvastatin.

Qian Y, Lei T, Patel P, Lee C, Monaghan-Nichols P, Xin H bioRxiv. 2021; .

PMID: 33594363 PMC: 7885915. DOI: 10.1101/2021.02.14.431174.

References

Crespo M, Zalacain J, Dunbar D, Cruz N, Arocho L . Cardiac oxidative stress is elevated at the onset of dilated cardiomyopathy in streptozotocin-diabetic rats. J Cardiovasc Pharmacol Ther. 2008; 13(1):64-71. DOI: 10.1177/1074248407307854. View

Wassmann S, Laufs U, Baumer A, Muller K, Ahlbory K, Linz W . HMG-CoA reductase inhibitors improve endothelial dysfunction in normocholesterolemic hypertension via reduced production of reactive oxygen species. Hypertension. 2001; 37(6):1450-7. DOI: 10.1161/01.hyp.37.6.1450. View

Adameova A, Harcarova A, Matejikova J, Pancza D, Kuzelova M, Carnicka S . Simvastatin alleviates myocardial contractile dysfunction and lethal ischemic injury in rat heart independent of cholesterol-lowering effects. Physiol Res. 2009; 58(3):449-454. DOI: 10.33549/physiolres.931751. View

van Leuven S, Kastelein J . Atorvastatin. Expert Opin Pharmacother. 2005; 6(7):1191-203. DOI: 10.1517/14656566.6.7.1191. View

Valko M, Leibfritz D, Moncol J, Cronin M, Mazur M, Telser J . Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol. 2006; 39(1):44-84. DOI: 10.1016/j.biocel.2006.07.001. View

Kume E, Aruga C, Ishizuka Y, Takahashi K, Miwa S, Itoh M . Gene expression profiling in streptozotocin treated mouse liver using DNA microarray. Exp Toxicol Pathol. 2005; 56(4-5):235-44. DOI: 10.1016/j.etp.2004.09.002. View

Chen Y, Ohmori K, Mizukawa M, Yoshida J, Zeng Y, Zhang L . Differential impact of atorvastatin vs pravastatin on progressive insulin resistance and left ventricular diastolic dysfunction in a rat model of type II diabetes. Circ J. 2006; 71(1):144-52. DOI: 10.1253/circj.71.144. View

Morrish N, Wang S, Stevens L, Fuller J, Keen H . Mortality and causes of death in the WHO Multinational Study of Vascular Disease in Diabetes. Diabetologia. 2001; 44 Suppl 2:S14-21. DOI: 10.1007/pl00002934. View

Huang B, Li F, Wu C, Wang D . The role of nitric oxide on rosuvastatin-mediated S-nitrosylation and translational proteomes in human umbilical vein endothelial cells. Proteome Sci. 2012; 10(1):43. PMC: 3533754. DOI: 10.1186/1477-5956-10-43. View

10.

Schafer A, Fraccarollo D, Eigenthaler M, Tas P, Firnschild A, Frantz S . Rosuvastatin reduces platelet activation in heart failure: role of NO bioavailability. Arterioscler Thromb Vasc Biol. 2005; 25(5):1071-7. DOI: 10.1161/01.ATV.0000161926.43967.df. View

11.

Dogra G, Watts G, Chan D, Stanton K . Statin therapy improves brachial artery vasodilator function in patients with Type 1 diabetes and microalbuminuria. Diabet Med. 2005; 22(3):239-42. DOI: 10.1111/j.1464-5491.2004.01382.x. View

12.

Ito D, Ito O, Mori N, Muroya Y, Cao P, Takashima K . Atorvastatin upregulates nitric oxide synthases with Rho-kinase inhibition and Akt activation in the kidney of spontaneously hypertensive rats. J Hypertens. 2010; 28(11):2278-88. DOI: 10.1097/HJH.0b013e32833e0924. View

13.

Guven G, Atalar E, Yavuz B, Beyazit Y, Kekilli M, Kilicarslan A . Simvastatin treatment improves endothelial function and increases fibrinolysis in patients with hypercholestrolemia. J Natl Med Assoc. 2006; 98(4):627-30. PMC: 2569240. View

14.

Crespo M, Moreta S, Gonzalez J . Cardiovascular deterioration in STZ-diabetic rats: possible role of vascular RAS. Pharmacology. 2003; 68(1):1-8. DOI: 10.1159/000068725. View

15.

Tantikosoom W, Thinkhamrop B, Kiatchusakul S, Jarernsiripornkul N, Srinakarin J, Ojongpian S . Randomized trial of atorvastatin in improving endothelial function in diabetics without prior coronary disease and having average cholesterol level. J Med Assoc Thai. 2005; 88(3):399-406. View

16.

Quidgley J, Cruz N, Crespo M . Atorvastatin improves systolic function, but does not prevent the development of dilated cardiomyopathy in streptozotocin-induced diabetic rats. Ther Adv Cardiovasc Dis. 2014; 8(4):133-144. DOI: 10.1177/1753944714531065. View

17.

Souza S, Flues K, Paulini J, Mostarda C, Rodrigues B, Souza L . Role of exercise training in cardiovascular autonomic dysfunction and mortality in diabetic ovariectomized rats. Hypertension. 2007; 50(4):786-91. DOI: 10.1161/HYPERTENSIONAHA.107.095000. View

18.

De Angelis K, Irigoyen M, Morris M . Diabetes and cardiovascular autonomic dysfunction: application of animal models. Auton Neurosci. 2008; 145(1-2):3-10. PMC: 2659465. DOI: 10.1016/j.autneu.2008.10.013. View

19.

Laufs U, La Fata V, Plutzky J, Liao J . Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors. Circulation. 1998; 97(12):1129-35. DOI: 10.1161/01.cir.97.12.1129. View

20.

Riad A, Du J, Stiehl S, Westermann D, Mohr Z, Sobirey M . Low-dose treatment with atorvastatin leads to anti-oxidative and anti-inflammatory effects in diabetes mellitus. Eur J Pharmacol. 2007; 569(3):204-11. DOI: 10.1016/j.ejphar.2007.04.065. View